OppenheimerFunds’s BioTelemetry, Inc. BEAT Stock Holding History

OppenheimerFunds’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$12.6M	Buy	+201,653	New	+$13.9M	0.02%	638
2018 Q4	–	Sell	-3,931	Closed	-$253K	–	1916
2018 Q3	$253K	Sell	3,931 -619	-14%	-$34.5K	﹤0.01%	1718
2018 Q2	$205K	Buy	+4,550	New	+$181K	﹤0.01%	1765
2017 Q3	–	Sell	-6,101	Closed	-$204K	–	1916
2017 Q2	$204K	Buy	+6,101	New	+$182K	﹤0.01%	1817

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds's BEAT Position: Q1 2019 in Review

OppenheimerFunds opened a new position in BioTelemetry, Inc. (BEAT) in Q1 2019: 201,653 shares worth $12.6M. The stake represents 0.02% of the portfolio and ranks #638 among its holdings. This is a return to the name: OppenheimerFunds previously reported a position in BEAT as recently as Q3 2018.

OppenheimerFunds first reported a position in BEAT in Q2 2017 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

OppenheimerFunds held 201,653 shares of BioTelemetry, Inc. worth $12.6M as of Q1 2019.
BioTelemetry, Inc. was a new OppenheimerFunds position in Q1 2019.
BioTelemetry, Inc. made up 0.02% of OppenheimerFunds's portfolio in Q1 2019, its #638 holding.
OppenheimerFunds first reported a position in BioTelemetry, Inc. in Q2 2017 and has held it in 4 quarters since.
311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.